$73.05
-1.04-1.40%
At close: -
$72.60
-0.45-0.61%
After Hours: 4:58 PM EDT
Comments
Loading...
AstraZeneca Earnings Estimates, EPS & Revenue | NASDAQ:AZN | Benzinga
AstraZeneca reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 29
EPS Estimate
$1.040
Quarterly Revenue Estimate
$14.20B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$54.07B
Analyze the earnings history of AstraZeneca using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AZN | AstraZeneca | $1.03 | $1.04 | — | — | $12.68B | $14.20B | — | — | 04/29/2025 | Get Alert |
| AZN | AstraZeneca | $0.72 | $1.07 | $1.04 | -2.34% | $12.02B | $14.21B | $14.89B | 4.79% | 02/06/2025 | Get Alert |
| AZN | AstraZeneca | $0.86 | $1.03 | $1.04 | 0.97% | $11.49B | $13.09B | $13.56B | 3.63% | 11/12/2024 | Get Alert |
| AZN | AstraZeneca | $1.07 | $1.20 | $0.99 | -17.50% | $11.42B | $12.75B | $12.98B | 1.83% | 07/25/2024 | Get Alert |
| AZN | AstraZeneca | $0.96 | $1.22 | $1.03 | -15.57% | $10.88B | $11.83B | $12.68B | 7.18% | 04/25/2024 | Get Alert |
| AZN | AstraZeneca | $0.69 | $0.79 | $0.72 | -8.23% | $11.21B | $12.09B | $12.02B | -0.55% | 02/08/2024 | Get Alert |
| AZN | AstraZeneca | $0.84 | $0.84 | $0.86 | 2.98% | $10.98B | $11.66B | $11.49B | -1.44% | 11/09/2023 | Get Alert |
| AZN | AstraZeneca | $0.86 | $0.95 | $1.07 | — | $10.77B | $10.96B | $11.42B | 4.16% | 07/28/2023 | Get Alert |
| AZN | AstraZeneca | $1.89 | $1.07 | $0.96 | -10.28% | $11.39B | $10.75B | $10.88B | 1.20% | 04/27/2023 | Get Alert |
| AZN | AstraZeneca | $0.84 | $0.67 | $0.69 | 2.99% | $12.01B | $11.21B | $11.21B | -0.03% | 02/09/2023 | Get Alert |
| AZN | AstraZeneca | $1.07 | $0.72 | $0.84 | 16.67% | $9.87B | $10.91B | $10.98B | 0.66% | 11/10/2022 | Get Alert |
| AZN | AstraZeneca | $0.45 | $0.77 | $0.86 | 11.69% | $8.22B | $10.53B | $10.77B | 2.29% | 07/29/2022 | Get Alert |
| AZN | AstraZeneca | $0.82 | $0.83 | $0.95 | 14.46% | $7.32B | $10.99B | $11.39B | 3.64% | 04/29/2022 | Get Alert |
| AZN | AstraZeneca | $0.54 | $0.73 | $0.84 | 15.07% | $7.41B | $10.88B | $12.01B | 10.40% | 02/10/2022 | Get Alert |
| AZN | AstraZeneca | $0.47 | $0.62 | $0.54 | -12.90% | $6.58B | $9.87B | $9.87B | -0.04% | 11/12/2021 | Get Alert |
| AZN | AstraZeneca | $0.48 | $0.43 | $0.45 | 4.65% | $6.28B | $7.36B | $8.22B | 11.68% | 07/29/2021 | Get Alert |
| AZN | AstraZeneca | $1.05 | $0.75 | $0.82 | 9.33% | $6.35B | $7.08B | $7.32B | 3.39% | 04/30/2021 | Get Alert |
| AZN | AstraZeneca | $0.45 | $0.68 | $0.54 | -20.59% | $6.66B | $6.97B | $7.41B | 6.31% | 02/11/2021 | Get Alert |
| AZN | AstraZeneca | $0.99 | $0.44 | $0.47 | 6.82% | $6.41B | $6.65B | $6.58B | -1.08% | 11/05/2020 | Get Alert |
| AZN | AstraZeneca | $0.73 | $0.44 | $0.48 | 9.09% | $5.82B | $6.24B | $6.28B | 0.56% | 07/30/2020 | Get Alert |
| AZN | AstraZeneca | $0.89 | $0.47 | $0.53 | 12.77% | $5.49B | $5.90B | $6.35B | 7.69% | 04/29/2020 | Get Alert |
AstraZeneca (AZN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-06 | $1.05 | $1.07 | -2.34 % |
| Q3 | 2024-11-12 | $1.04 | $1.03 | 0.97 % |
| Q2 | 2024-07-25 | $0.99 | $1.20 | -17.5 % |
| Q1 | 2024-04-25 | $1.03 | $1.22 | -15.6 % |
AstraZeneca (AZN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-06 | $14.89B | $14.21B | 4.79 % |
| Q3 | 2024-11-12 | $13.57B | $13.09B | 3.63 % |
| Q2 | 2024-07-25 | $12.98B | $12.75B | 1.83 % |
| Q1 | 2024-04-25 | $12.68B | $11.83B | 7.18 % |
FAQ
When is AstraZeneca (NASDAQ:AZN) reporting earnings?
AstraZeneca (AZN) is scheduled to report earnings on April 29, 2025. The last reported earnings were for reported on February 6, 2025 for Q4.
What were the latest earnings per share (EPS) for AstraZeneca (NASDAQ:AZN)?
The Actual EPS was $1.05, which missed the estimate of $1.07.
What were AstraZeneca’s (NASDAQ:AZN) revenues?
The Actual Revenue was $14.9B, which beat the estimate of $14.2B.
Browse earnings estimates, EPS, and revenue on all stocks.